The document summarizes a study examining whether patients whose physicians have financial incentives to control costs receive care at lower-priced hospitals. The study uses California hospital discharge data from 2003 to estimate models of hospital choice. Preliminary results from multinomial logit analyses found the price coefficient was positive when insurers and patients were pooled, but negative for less-sick patients and more negative for insurers with high rates of capitated payments to physicians. Inequalities analyses found the price coefficient was negative for almost all insurers when patients were pooled, and more negative for insurers with high capitation rates.
This document discusses the use of group-based incentives, known as gainsharing programs, between hospitals and cardiologists. It presents a theoretical framework for why such incentives could help align the incentives of physicians with the cost considerations of hospitals. The document outlines an empirical study that will test the effects of gainsharing programs on stent costs, quantities, and prices using data from hospitals that have implemented these programs. It will examine whether gainsharing leads to standardization, lower device prices through volume discounts, and a market response from medical device manufacturers.
Classifying Readmissions of Diabetic Patient EncountersMayur Srinivasan
Readmission rates in hospitals are a key indicator on quality of patient care and a clear indication of total cost or inconvenience related to the treatment. Patients with serious medical
conditions such as diabetes mellitus are key drivers of readmission rates owing to the complexity of their illness. Therefore, being able to predict based on certain features whether or not a patient
will need readmission can help doctors and hospitals provide better care initially and not get financially penalized under Obamacare’s readmission policy
This document provides a summary of a project to analyze factors related to readmission of diabetes patients using a dataset from 130 US hospitals. The team cleaned the data by removing attributes with high percentages of missing values, irrelevant attributes, and instances of deceased patients. They applied the SMOTE technique to address data imbalance, oversampling the minority readmission class by 200%. Three classifiers - J48 decision tree, Naive Bayes, and Bayes Net - were selected for experiments to predict patient readmission.
Should Drug Prices Differ by Indication? Outlining the debate on indication-b...Office of Health Economics
The notion that the price of a medicine should be linked in some way to the value it generates for patients and the health system is generally accepted. Yet, how can this be achieved when, increasingly, medicines are being developed that derive patient across many different indications? We summarise the current state-of-play for indication-based pricing (IBP), both in theory as described in the key literature, and in practice by investigating its use in the US and five major European countries.
Author(s) and affiliations(s): Amanda Cole, OHE Bernarda Zamora, OHE Adrian Towse, OHE
Conference/meeting: ISPOR Europe
Event location: ISPOR Europe
Date: 13/11/2018
Advanced Diagnostics in the Post-PAMA EraJohn Hanna
The document discusses trends impacting molecular diagnostics reimbursement, including:
1) Commercial payers are increasingly adopting strategies like specialty drug carve-outs, step therapies, prior authorization, and utilization management programs to contain costs, similar to strategies used for specialty drugs.
2) Reference pricing and lab benefit management programs that provide price transparency and incentivize use of lower-cost providers have been associated with reduced prices and spending while maintaining patient access.
3) Post-PAMA reforms like ADLT designation and Medicare clinical lab fee schedule updates aim to balance innovation and access for new tests, but challenges remain around coding, rate-setting, and determining what constitutes "new clinical information".
Value of Medication Adherence in Chronic Vascular Disease: Fixed Effects Mode...M. Christopher Roebuck
This document summarizes a study that examined the impact of medication adherence on health services utilization and costs for patients with chronic vascular conditions. The study used claims data from over 135,000 patients to measure adherence rates and model the relationship between adherence and outcomes. The results showed that optimal adherence was associated with higher pharmacy costs but lower medical costs, leading to overall savings. Adherence had a greater impact on reducing utilization and costs for elderly patients compared to non-seniors.
This document summarizes a presentation on how patient preference studies contribute to personalized medicine. It discusses when preference studies are conducted, common methods for assessing preferences, and applications in personalized medicine. An example is given of a preference study on treatment options for shoulder dislocation, showing how preferences can vary between individuals. Whole genome sequencing is also discussed as an area where preferences are complex, with patients valuing different aspects. Preference studies aim to better engage patients in medical decisions by accounting for heterogeneity in what patients value.
This document discusses the use of group-based incentives, known as gainsharing programs, between hospitals and cardiologists. It presents a theoretical framework for why such incentives could help align the incentives of physicians with the cost considerations of hospitals. The document outlines an empirical study that will test the effects of gainsharing programs on stent costs, quantities, and prices using data from hospitals that have implemented these programs. It will examine whether gainsharing leads to standardization, lower device prices through volume discounts, and a market response from medical device manufacturers.
Classifying Readmissions of Diabetic Patient EncountersMayur Srinivasan
Readmission rates in hospitals are a key indicator on quality of patient care and a clear indication of total cost or inconvenience related to the treatment. Patients with serious medical
conditions such as diabetes mellitus are key drivers of readmission rates owing to the complexity of their illness. Therefore, being able to predict based on certain features whether or not a patient
will need readmission can help doctors and hospitals provide better care initially and not get financially penalized under Obamacare’s readmission policy
This document provides a summary of a project to analyze factors related to readmission of diabetes patients using a dataset from 130 US hospitals. The team cleaned the data by removing attributes with high percentages of missing values, irrelevant attributes, and instances of deceased patients. They applied the SMOTE technique to address data imbalance, oversampling the minority readmission class by 200%. Three classifiers - J48 decision tree, Naive Bayes, and Bayes Net - were selected for experiments to predict patient readmission.
Should Drug Prices Differ by Indication? Outlining the debate on indication-b...Office of Health Economics
The notion that the price of a medicine should be linked in some way to the value it generates for patients and the health system is generally accepted. Yet, how can this be achieved when, increasingly, medicines are being developed that derive patient across many different indications? We summarise the current state-of-play for indication-based pricing (IBP), both in theory as described in the key literature, and in practice by investigating its use in the US and five major European countries.
Author(s) and affiliations(s): Amanda Cole, OHE Bernarda Zamora, OHE Adrian Towse, OHE
Conference/meeting: ISPOR Europe
Event location: ISPOR Europe
Date: 13/11/2018
Advanced Diagnostics in the Post-PAMA EraJohn Hanna
The document discusses trends impacting molecular diagnostics reimbursement, including:
1) Commercial payers are increasingly adopting strategies like specialty drug carve-outs, step therapies, prior authorization, and utilization management programs to contain costs, similar to strategies used for specialty drugs.
2) Reference pricing and lab benefit management programs that provide price transparency and incentivize use of lower-cost providers have been associated with reduced prices and spending while maintaining patient access.
3) Post-PAMA reforms like ADLT designation and Medicare clinical lab fee schedule updates aim to balance innovation and access for new tests, but challenges remain around coding, rate-setting, and determining what constitutes "new clinical information".
Value of Medication Adherence in Chronic Vascular Disease: Fixed Effects Mode...M. Christopher Roebuck
This document summarizes a study that examined the impact of medication adherence on health services utilization and costs for patients with chronic vascular conditions. The study used claims data from over 135,000 patients to measure adherence rates and model the relationship between adherence and outcomes. The results showed that optimal adherence was associated with higher pharmacy costs but lower medical costs, leading to overall savings. Adherence had a greater impact on reducing utilization and costs for elderly patients compared to non-seniors.
This document summarizes a presentation on how patient preference studies contribute to personalized medicine. It discusses when preference studies are conducted, common methods for assessing preferences, and applications in personalized medicine. An example is given of a preference study on treatment options for shoulder dislocation, showing how preferences can vary between individuals. Whole genome sequencing is also discussed as an area where preferences are complex, with patients valuing different aspects. Preference studies aim to better engage patients in medical decisions by accounting for heterogeneity in what patients value.
PCOMS and an Acute Care Inpatient Unit: Quality Improvement and Reduced Readm...Barry Duncan
High psychiatric readmission rates continue while evidence suggests that care is not perceived by patients as “patient centered.” Research has focused on aftercare strategies with little attention to the inpatient treatment itself as an intervention to reduce readmission rates. Quality improvement strategies based on patient-centered care may offer an alternative. We evaluated outcomes and readmission rates using a benchmarking methodology with a naturalistic data set from an inpatient psychiatric facility (N 2,247) that used a quality-improvement strategy called systematic patient feedback. A systematic patient feedback system, the Partners for Change Outcome Management System (PCOMS), was used. Overall pre-post effect sizes were d 1.33 and d 1.38 for patients diagnosed with a mood
disorder. These effect sizes were statistically equivalent to RCT benchmarks for feedback and depression.
Readmission rates were 6.1% (30 days), 9.5% (60 days), and 16.4% (180 days), all lower than national benchmarks. We also found that patients who achieved clinically significant treatment outcomes were less likely to be readmitted. We tentatively suggest that a focus on real-time patient outcomes as well as care that is “patient centered” may provide lower readmission rates.
This study evaluated the implementation of a value-driven outcomes tool at University of Utah Health Care to measure costs, quality, and outcomes at the individual patient level. The tool identified high variability in costs for certain conditions like sepsis and joint replacements. For three clinical projects using the tool (total joint replacement, hospitalist laboratory testing, and sepsis management), costs decreased 7-11% and quality improved. The tool was associated with reduced costs and better outcomes when used to provide clinicians information on resource use and performance for defined patient populations.
The document describes a study that investigated how patients react to information about their physicians' conflicts of interest (COI). Participants were randomly assigned to one of three disclosure conditions (no, partial, or full disclosure) and asked their treatment preference. Increased disclosure significantly increased the likelihood patients would reject the physician's recommendation and choose drug therapy instead of an invasive procedure. On average, participants felt confident in their treatment choices across all disclosure levels.
The document discusses the growing importance of demonstrating value through evidence for biotech companies when engaging with payers. It outlines how health technology assessments and real-world evidence are being used by payers globally to determine coverage, reimbursement, and contracting. Additionally, it explores emerging innovative contracting models between payers and manufacturers that are shifting focus to outcomes over utilization and sharing risk.
The document discusses the growing importance of demonstrating value through evidence for biotech companies when engaging with payers. It outlines how health technology assessments and real-world evidence are being used by payers globally to determine coverage, reimbursement, and contracting. Additionally, it explores emerging innovative contracting models between payers and manufacturers that are shifting focus to outcomes over utilization and sharing risk.
Adjusting for Differential Item Functioning in the EQ-5D-5L Using Externally-...Office of Health Economics
Paula and Rachel's presentation on adjusting for differential item functioning in the EQ-5Q-5L using externally-collected vignettes given at the 2017 iHEA World Conference in Boston.
Laos: Hospital treatment costs and tertiary careHealthSpace.Asia
The Regional Forum on Health Care Financing on its 2nd day (3 May 2012) started with a keynote from Prof. Soonman Kwon on Asia health financing experience. Other presentations covered the issue of hospital financing and primary care financing. Very insightful as the first day.
Predicting Hospital Readmission Using TreeNetSalford Systems
This document discusses using a TreeNet model to predict hospital readmissions using data from electronic medical records (EMRs). It provides an overview of the dataset used, which includes over 1,000 clinical and administrative variables for 1,612 heart failure patients. The document describes how TreeNet was used to create a predictive model from the EMR data, including feature selection and parameter tuning. It also discusses evaluating the model, assessing variable importance, and exploring model results to gain clinical insights. The goal is to develop an accurate model that can help reduce the risk of avoidable hospital readmissions.
Clinical significance refers to the practical or noticeable importance of a treatment effect in daily life. There are three main types of significance: statistical significance, which relates to hypothesis testing; practical significance, which measures treatment effectiveness through metrics like effect size; and clinical significance, which determines if treatment is effective enough to change a patient's diagnosis. Various methods can calculate clinical significance, such as the Jacobson-Truax method involving a reliability change index to categorize patients.
Are you interested in learning how to prevent hospital readmissions for your diabetic population? It is a popular belief that measuring blood glucose for your diabetic population is the most predictive variable in determining a hospital readmission for a diabetic. However, many providers of care simply do not perform the test on known diabetic patients. This study takes a look at an advanced analytic method that works within the current healthcare providers workflow to looks to identify the likelihood of a future 30-day unplanned readmission before hospital discharge.
Archives of Physical Medicine and Rehabilitation 2013 BennettChristian Niedzwecki
This study analyzed data on over 21,000 children with traumatic brain injury (TBI) to examine factors associated with receiving physical, occupational, and speech therapy evaluations during hospitalization. The results showed that 41% received a physical or occupational therapy evaluation, while 26% received a speech or swallow evaluation. Older children, those with more severe injuries, fractures, and certain medical treatments were more likely to receive evaluations. Evaluations most commonly occurred around 5-7 days after admission. There was wide variation between hospitals, from 11-74% for physical/occupational therapy evaluations and 4-55% for speech/swallow evaluations, suggesting the need for evidence-based guidelines on initiating rehabilitation therapies after pediatric TBI.
This study evaluated the risk of opioid abuse in 202 chronic pain patients by addiction psychiatry fellows in an academic pain center. Most consultations were requested by less experienced pain practitioners and focused on assessing risk of continued opioid therapy. Abnormal toxicology results were found in 63% of patients referred, and only 2% were ultimately recommended for continued opioid therapy. The addiction psychiatry fellows found this rotation valuable for their training in evaluating prescription opioid risk. The study suggests supervised addiction psychiatry fellows can effectively conduct opioid risk assessments.
1. The study compared the sensitivity to change of the standard 42-item Obsessive Compulsive Inventory (OCI), the revised 18-item version (OCI-R), and a shorter version focusing on the highest subscale (OCI-R Main) in two cohorts of patients with different OCD severity who received cognitive behavioral therapy.
2. The results showed that the OCI-R is a valid self-report measure for assessing change and is less burdensome for patients than the full OCI. However, questions remain about whether the OCI or OCI-R are sensitive enough to detect changes for service evaluation purposes.
3. All versions of the OCI were less sensitive to changes
Microsoft in Healthcare Analytics Georgia HIMSS Perficient, Inc.
This document discusses Microsoft's partnership with Perficient and how they help healthcare organizations with business intelligence and analytics using the Microsoft stack. It provides examples of two customer engagements: Meriter Health Systems implemented a cost containment dashboard and integrated clinical and financial systems using Microsoft technologies. DuPage Medical Group leveraged their existing SQL Server infrastructure to encourage self-service reporting and provide advanced analytics capabilities. The document concludes with Perficient's expertise in BI strategies, design, architecture, implementation, education and various disciplines like data integration and warehousing, reporting and analytics.
Medipex innovation awards 2015 press releaseScott Miller
The document summarizes the winners of the eleventh annual Medipex NHS Innovation Awards and Showcase. Seven teams were awarded across five categories for their innovative projects that improve patient care and make NHS services more efficient. The winners included mobile apps to improve doctor training feedback and patient communication, and initiatives to deliver intravenous treatments and orthotics at home. The awards recognize pioneering ideas developed collaboratively between NHS staff, universities, charities, and businesses.
This document discusses engaging physicians in clinical redesign efforts to improve hospital finances. It begins by providing background on declining hospital margins in recent years and increasing financial pressures going forward. It then outlines six key steps to engaging physicians: 1) Define the need and vision; 2) Share detailed clinical cost data; 3) Establish shared authority and responsibility; 4) Provide structure and guidance through committees; 5) Focus on initiatives that reduce costs while maintaining or improving quality; 6) Incentivize physician participation. It emphasizes the importance of physician leadership and buy-in for successful redesign. It also addresses potential pitfalls and ways to gain physician alignment, such as addressing quality concerns, translating data effectively, and clarifying expectations around incentives
Commercial reasonableness in_exempt_hospital_transactions_annotated_4.28.2014Robert James Cimasi
This was from a presentation given to one of the ASA Chapters titled, "Commercial Reasonableness in Exempt Hospital Transactions: Hurdling the Analytical Thresholds". The presentation covers healthcare specific topics around: fair market value; commercial reasonableness; fraud and abuse enforcement; and, relevant case law.
Healthcare Valuations in an Era of Reform and UncertaintyPYA, P.C.
PYA Principal Jim Lloyd's AICPA Health Care Industry Conference presentation explored reform and current environment highlights, healthcare transactions and affiliations, valuation considerations, and regulatory issues.
A contractor’s guide to the future of healthcare facilitiesMark Farnsworth
Technology, infection control, and sustainability will all help to shape the future of healthcare construction. Learn more here: http://hubs.ly/H03l8Y20
PCOMS and an Acute Care Inpatient Unit: Quality Improvement and Reduced Readm...Barry Duncan
High psychiatric readmission rates continue while evidence suggests that care is not perceived by patients as “patient centered.” Research has focused on aftercare strategies with little attention to the inpatient treatment itself as an intervention to reduce readmission rates. Quality improvement strategies based on patient-centered care may offer an alternative. We evaluated outcomes and readmission rates using a benchmarking methodology with a naturalistic data set from an inpatient psychiatric facility (N 2,247) that used a quality-improvement strategy called systematic patient feedback. A systematic patient feedback system, the Partners for Change Outcome Management System (PCOMS), was used. Overall pre-post effect sizes were d 1.33 and d 1.38 for patients diagnosed with a mood
disorder. These effect sizes were statistically equivalent to RCT benchmarks for feedback and depression.
Readmission rates were 6.1% (30 days), 9.5% (60 days), and 16.4% (180 days), all lower than national benchmarks. We also found that patients who achieved clinically significant treatment outcomes were less likely to be readmitted. We tentatively suggest that a focus on real-time patient outcomes as well as care that is “patient centered” may provide lower readmission rates.
This study evaluated the implementation of a value-driven outcomes tool at University of Utah Health Care to measure costs, quality, and outcomes at the individual patient level. The tool identified high variability in costs for certain conditions like sepsis and joint replacements. For three clinical projects using the tool (total joint replacement, hospitalist laboratory testing, and sepsis management), costs decreased 7-11% and quality improved. The tool was associated with reduced costs and better outcomes when used to provide clinicians information on resource use and performance for defined patient populations.
The document describes a study that investigated how patients react to information about their physicians' conflicts of interest (COI). Participants were randomly assigned to one of three disclosure conditions (no, partial, or full disclosure) and asked their treatment preference. Increased disclosure significantly increased the likelihood patients would reject the physician's recommendation and choose drug therapy instead of an invasive procedure. On average, participants felt confident in their treatment choices across all disclosure levels.
The document discusses the growing importance of demonstrating value through evidence for biotech companies when engaging with payers. It outlines how health technology assessments and real-world evidence are being used by payers globally to determine coverage, reimbursement, and contracting. Additionally, it explores emerging innovative contracting models between payers and manufacturers that are shifting focus to outcomes over utilization and sharing risk.
The document discusses the growing importance of demonstrating value through evidence for biotech companies when engaging with payers. It outlines how health technology assessments and real-world evidence are being used by payers globally to determine coverage, reimbursement, and contracting. Additionally, it explores emerging innovative contracting models between payers and manufacturers that are shifting focus to outcomes over utilization and sharing risk.
Adjusting for Differential Item Functioning in the EQ-5D-5L Using Externally-...Office of Health Economics
Paula and Rachel's presentation on adjusting for differential item functioning in the EQ-5Q-5L using externally-collected vignettes given at the 2017 iHEA World Conference in Boston.
Laos: Hospital treatment costs and tertiary careHealthSpace.Asia
The Regional Forum on Health Care Financing on its 2nd day (3 May 2012) started with a keynote from Prof. Soonman Kwon on Asia health financing experience. Other presentations covered the issue of hospital financing and primary care financing. Very insightful as the first day.
Predicting Hospital Readmission Using TreeNetSalford Systems
This document discusses using a TreeNet model to predict hospital readmissions using data from electronic medical records (EMRs). It provides an overview of the dataset used, which includes over 1,000 clinical and administrative variables for 1,612 heart failure patients. The document describes how TreeNet was used to create a predictive model from the EMR data, including feature selection and parameter tuning. It also discusses evaluating the model, assessing variable importance, and exploring model results to gain clinical insights. The goal is to develop an accurate model that can help reduce the risk of avoidable hospital readmissions.
Clinical significance refers to the practical or noticeable importance of a treatment effect in daily life. There are three main types of significance: statistical significance, which relates to hypothesis testing; practical significance, which measures treatment effectiveness through metrics like effect size; and clinical significance, which determines if treatment is effective enough to change a patient's diagnosis. Various methods can calculate clinical significance, such as the Jacobson-Truax method involving a reliability change index to categorize patients.
Are you interested in learning how to prevent hospital readmissions for your diabetic population? It is a popular belief that measuring blood glucose for your diabetic population is the most predictive variable in determining a hospital readmission for a diabetic. However, many providers of care simply do not perform the test on known diabetic patients. This study takes a look at an advanced analytic method that works within the current healthcare providers workflow to looks to identify the likelihood of a future 30-day unplanned readmission before hospital discharge.
Archives of Physical Medicine and Rehabilitation 2013 BennettChristian Niedzwecki
This study analyzed data on over 21,000 children with traumatic brain injury (TBI) to examine factors associated with receiving physical, occupational, and speech therapy evaluations during hospitalization. The results showed that 41% received a physical or occupational therapy evaluation, while 26% received a speech or swallow evaluation. Older children, those with more severe injuries, fractures, and certain medical treatments were more likely to receive evaluations. Evaluations most commonly occurred around 5-7 days after admission. There was wide variation between hospitals, from 11-74% for physical/occupational therapy evaluations and 4-55% for speech/swallow evaluations, suggesting the need for evidence-based guidelines on initiating rehabilitation therapies after pediatric TBI.
This study evaluated the risk of opioid abuse in 202 chronic pain patients by addiction psychiatry fellows in an academic pain center. Most consultations were requested by less experienced pain practitioners and focused on assessing risk of continued opioid therapy. Abnormal toxicology results were found in 63% of patients referred, and only 2% were ultimately recommended for continued opioid therapy. The addiction psychiatry fellows found this rotation valuable for their training in evaluating prescription opioid risk. The study suggests supervised addiction psychiatry fellows can effectively conduct opioid risk assessments.
1. The study compared the sensitivity to change of the standard 42-item Obsessive Compulsive Inventory (OCI), the revised 18-item version (OCI-R), and a shorter version focusing on the highest subscale (OCI-R Main) in two cohorts of patients with different OCD severity who received cognitive behavioral therapy.
2. The results showed that the OCI-R is a valid self-report measure for assessing change and is less burdensome for patients than the full OCI. However, questions remain about whether the OCI or OCI-R are sensitive enough to detect changes for service evaluation purposes.
3. All versions of the OCI were less sensitive to changes
Microsoft in Healthcare Analytics Georgia HIMSS Perficient, Inc.
This document discusses Microsoft's partnership with Perficient and how they help healthcare organizations with business intelligence and analytics using the Microsoft stack. It provides examples of two customer engagements: Meriter Health Systems implemented a cost containment dashboard and integrated clinical and financial systems using Microsoft technologies. DuPage Medical Group leveraged their existing SQL Server infrastructure to encourage self-service reporting and provide advanced analytics capabilities. The document concludes with Perficient's expertise in BI strategies, design, architecture, implementation, education and various disciplines like data integration and warehousing, reporting and analytics.
Medipex innovation awards 2015 press releaseScott Miller
The document summarizes the winners of the eleventh annual Medipex NHS Innovation Awards and Showcase. Seven teams were awarded across five categories for their innovative projects that improve patient care and make NHS services more efficient. The winners included mobile apps to improve doctor training feedback and patient communication, and initiatives to deliver intravenous treatments and orthotics at home. The awards recognize pioneering ideas developed collaboratively between NHS staff, universities, charities, and businesses.
This document discusses engaging physicians in clinical redesign efforts to improve hospital finances. It begins by providing background on declining hospital margins in recent years and increasing financial pressures going forward. It then outlines six key steps to engaging physicians: 1) Define the need and vision; 2) Share detailed clinical cost data; 3) Establish shared authority and responsibility; 4) Provide structure and guidance through committees; 5) Focus on initiatives that reduce costs while maintaining or improving quality; 6) Incentivize physician participation. It emphasizes the importance of physician leadership and buy-in for successful redesign. It also addresses potential pitfalls and ways to gain physician alignment, such as addressing quality concerns, translating data effectively, and clarifying expectations around incentives
Commercial reasonableness in_exempt_hospital_transactions_annotated_4.28.2014Robert James Cimasi
This was from a presentation given to one of the ASA Chapters titled, "Commercial Reasonableness in Exempt Hospital Transactions: Hurdling the Analytical Thresholds". The presentation covers healthcare specific topics around: fair market value; commercial reasonableness; fraud and abuse enforcement; and, relevant case law.
Healthcare Valuations in an Era of Reform and UncertaintyPYA, P.C.
PYA Principal Jim Lloyd's AICPA Health Care Industry Conference presentation explored reform and current environment highlights, healthcare transactions and affiliations, valuation considerations, and regulatory issues.
A contractor’s guide to the future of healthcare facilitiesMark Farnsworth
Technology, infection control, and sustainability will all help to shape the future of healthcare construction. Learn more here: http://hubs.ly/H03l8Y20
Key Growth Sectors in the Health Care Services M&A MarketRobert James Cimasi
The document discusses a webcast on key growth sectors in the health care M&A market. It provides an agenda that will discuss trends in hospital, physician groups, managed care, and financing. It then introduces several speakers who will provide perspectives on health care services M&A trends.
In “Valuing Healthcare Management Services Agreements,” PYA Principal Tynan Olechny discussed the types of management services found in the healthcare marketplace. Her NACVA webinar presentation addressed the valuation of these services with a focus on how the appraiser can analyze the key economics of management services agreements. She also examined how the commercial reasonableness of these arrangements can be evaluated and assessed as part of the valuation process.
WHAT IF: Financial incentives were better aligned across hospital and communi...CFHI-FCASS
This document discusses aligning financial incentives across hospital and community care settings through combining activity-based funding and global budgets. Currently, funding policies are not aligned, creating disincentives for efficient patient flow. The proposed option is blending activity-based funding and global budgets for acute and post-acute care separately. While activity-based funding generally promotes volume and efficiency in hospitals, its impact on costs and capacity in post-acute care is unknown. Transitioning patients between facilities also poses challenges under this model.
A step-by-step methodology to evaluate a department's revenue stream. Identifiy and assess mission-critical revenue trends to prompt remedies and compromises that maintain the revenue stream.
This document summarizes accounting and finance reporting changes that healthcare organizations need to be aware of, including:
- New guidance on accounting for electronic health record incentives from Medicare and Medicaid.
- Updates to accounting for Recovery Audit Contractor claim adjustments and exposures.
- Clarified auditing standards issued by auditing standard setters.
- Recent updates from FASB including new disclosure requirements for bad debts and allowances as well as accounting for malpractice claims and insurance recoveries.
PYA Principal Carol Carden presented “Fundamentals of Healthcare Valuation” at the American Society of Appraisers (ASA) 2015 Advanced Business Valuation Conference. The presentation explored unique characteristics of the healthcare industry, particularly those relevant to appraisers for avoiding common mistakes in assessing risk and projecting cash flow.
This document outlines the topics that will be covered in a financial management course for hospital executives. The course will cover fundamental financial management concepts like risks and rates of return, time value of money, and financial assets. It will also cover topics like capital budgeting, capital structure, working capital management, and financial planning. The document notes that financial management involves planning, directing, monitoring, organizing and controlling an organization's monetary resources. It aims to help organizations achieve financial objectives like profitability, risk control, and meeting stakeholder expectations.
This document provides information about a healthcare supply chain conference taking place in Dubai in April 2014. The two-day conference will bring together healthcare regulators, providers, distributors, and manufacturers to discuss strategies for developing robust and strategic healthcare supply chains.
The conference will feature keynote speeches from leaders in the UAE Ministry of Health and hospital supply chain management. Participants can attend panels on designing resilient supply chain networks, regulatory developments, and managing relationships with suppliers and internal stakeholders. Interactive sessions will address topics like demand planning, eliminating inefficiencies, and developing effective inventory management. The goal is to help attendees implement transformational supply chain models that improve patient outcomes and care.
This document describes Zulekha Hospital's implementation of a Balanced Scorecard approach to strategic planning and performance measurement. It outlines how Zulekha developed a strategy map and scorecard with objectives in four perspectives: financial, customer, internal processes, and learning and growth. Metrics and initiatives were identified for each objective. The scorecard approach was then cascaded down to the radiology department to increase accountability and align goals across the organization. Implementing the Balanced Scorecard provided Zulekha with a common framework to communicate strategy, track performance, and improve patient satisfaction.
Waste in hospitals - everywhere - is massive. Up to 50% of consumables and devices purchased are never used on a patient. Support activities are highly manual, repetitive and done by professional clinical staff...
This presentation sets out the strategic environment and discusses the development and successful implementation of a leading-edge process and supply chain solution for hospitals.
How to Sustain Healthcare Quality Improvement in 3 Critical StepsHealth Catalyst
Many healthcare organizations don’t hold quality and cost gains because they don’t make improvement the backbone of their organization. Rather, they approach improvement as a series of initiatives. Ronald D. Snee, a fellow with the American Society for Quality states, “Many organizations focus on sustaining the gains only after improvement has been achieved. Intuitively, that may seem the correct sequence, but it is in fact backwards. The time to focus on sustaining improvement gains is well before the initiative is launched.”
Here are 3 critical organizational steps that can help sustain those gains.
Hospital and Healthcare System Strategic Planning and Financial ForecastingAxiom EPM
Given the level of uncertainty in the healthcare industry and all of the external factors that impact healthcare provider organizations today, strategic planning has become an increasingly complex function. The process is no longer a simple financial forecasting exercise. Instead, it has evolved into a more integrated financial and operational planning activity that touches the entire organization. The process of defining a multi-year financial forecast is now predicated on the modeling of individual business initiatives focused on cost reduction or revenue growth. These slides present four factors vital to establishing more agile strategic planning models. You'll learn techniques to incorporate financial and service line-based analytics to enable efficient ‘what-if’ modeling, scenario analysis and initiative-based modeling and tracking.
5 Keys to Improving Hospital Labor ProductivityHealth Catalyst
The shift to value-based payments and a greater focus outcomes and cost reduction has hospital leaders seeking new ways to work more efficiently and improve patient satisfaction. Monitoring and analyzing productivity more effectively is crucial to ensure healthcare organizations are aligned with this goal. Getting overtime and labor productivity under control isn’t an easy task, but it’s not impossible. A few best practices can shorten the learning curve. These include 1) secure leadership commitment, 2) implement data governance, 3) ensure financial targets are defined, 4) create transparency, and 5) keep productivity metric balanced with quality goals.
The document discusses the history, meaning, and process of budgeting. It provides key details on:
- The origins of the term "budget" from the British Kings in the early days.
- The main stages in budget development including formulation, review/enactment, and execution.
- The types of budgets such as operating, capital, cash, and personal budgets.
- The roles and responsibilities of those involved in budget planning and implementation, including nurse managers.
- The overall goal of budgeting to estimate and control expenses and income over a set period of time through a formal financial planning process.
Here at Financial Hospital we build a solid foundation for you to reach your desired destiny of financial stability through proper foundation and execution of financial planning as well as financial goals. As ever, we would like to be a part of your success. Since 2004, Financial Hospital has successfully serviced each and every client's from India or abroad. Be it Financial Planning, Tax advice or investment planning in equity, debt or alternate category; our team backed by strong research and latest economic trends, are always ready to serve our beloved investor's any queries or needs. Today, with the rich experience of our professional team comprise of CA's, MBA''s, CFP's and other technocrats, a thorough knowledge of the markets, strong leadership, innovative and focused research and having 7 office across India, Financial Hospital itself defines its value and success story.
Learn about reference pricing as a purchaser in response to the high and rising pharmaceutical sales and innovative strategies for managing specialty drugs.
WHAT IF: Group-based profit-sharing strategies aligned physician incentives w...CFHI-FCASS
There is currently a misalignment of incentives between hospitals and physicians in Canada's healthcare system. Hospitals bear the costs of drugs and devices but have little control over physician choices. Gainsharing programs could help by allowing hospitals to provide bonuses to physicians based on cost savings as a team. This could incentivize physicians to consider costs when choosing cheaper drugs and devices, standardizing choices to increase hospital rebates. Evidence from the US shows gainsharing reduced costs for stent procedures through lower prices paid rather than reducing care quality or quantity. With proper safeguards, gainsharing may help decrease healthcare costs in Canada by better aligning hospital and physician incentives.
Payer Mix and EHR Adoptionin HospitalsDong Yeong Shin, doc.docxdanhaley45372
Payer Mix and EHR Adoption
in Hospitals
Dong Yeong Shin, doctoral student. Department of Health Services Administration,
University of Alabama at Birmingham; Nir Menachemi, PhD, professor, health care
organization and policy. University of Alabama at Birmingham; Mark Diana, PhD,
assistant professor. School of Public Health, Tulane University, New Orleans; Abby
Swanson Kazley, PhD, associate professor. Medical University of South Carolina,
Charleston; and Eric W. Ford, PhD, distinguished professor of healthcare, Bryan School
of Business, University of North Carolina at Creensboro
E X E C U T I V E S U M M A R Y
Payers are known to influence the adoption of health informarion technology (HIT)
among hospitals. However, previous studies examining the relationship between
payer mix and HIT have not focused specifically on electronic health record systems
(EHRs). Using data from the Nationwide Inpatient Sample and the American Hos-
pital Association Annual Survey, we examine how Medicare, Medicaid, commercial
insurance, and managed care caseloads are associated with EHR adoption in hospi-
tals. Overall, we found a weak relationship between payer mix and EHR adoption.
Medicare and, separately, Medicaid volumes were not associated with EHR adoption.
Furthermore, commercial insurance volume was not associated with EHR adoption;
however, a hospital located in the third quartile of managed care caseloads had a
decreased likelihood of EHR adoption. We did not find empirical evidence to sup-
port the hypothesis that payer generosity and other indirect mechanisms influence
EHR adoption in hospitals. The direct incentives embedded in the Health Informa-
tion Technology for Economic and Clinical Health Act may have a positive influence
on EHR adoption—especially for hospitals with high Medicare and/or Medicaid
caseloads. However, it is still uncertain whether the available incentives will offset the
barriers many hospitals face in achieving meaningfijl use of EHRs.
For more information about the concepts in this article, contact Dr. Menachemi
at [email protected]
435
JOURNAL O F HEALTHCARE M A N A G E M E N T 5 7 : 6 N O V E M B E R / D E C E M B E R 2 0 1 2
I N T R O D U C T I O N
Research has shown that payer mix,
defined as the combination of third-
party payers that makes up a hospital's
book of business, can influence hospi-
tals' strategic behaviors. Studies have
found that higher percentages of Medic-
aid (Cleverley and Harvey 1992; McKay
and Deily 2005) or Medicare patients
(Rosko 2001) are negatively associated
with financial performance. Further-
more, given that varying reimburse-
ment rates are negotiated in the private
insurance book of business, hospital
revenue per admission has been demon-
strated to predict operational efficiency
(Dor and Fariey 1996; McKay and Deily
2005) and clinical performance (Clem-
ent and Crazier 2001; Menachemi et al.
2007). Attempting to leverage the influ-
ence that the public insurance programs
have on hospi.
Accounting and Medicine An ExploratoryInvestigation into .docxnettletondevon
Accounting and Medicine: An Exploratory
Investigation into Physicians’ Attitudes
Toward the Use of Standard
Cost-Accounting Methods in Medicine
Greg M. Thibadoux
Marsha Scheidt
Elizabeth Luckey
ABSTRACT. Research studies demonstrate wide varia-
tion in how physicians diagnose and treat patients with
similar medical conditions and suggest that at least some
of the variation reflects inefficiencies and unnecessary
medical costs. Health care researchers are actively exam-
ining ways to reduce variations in practice through
standardization of medicine to reduce the cost of treat-
ment and ensure the quality of outcomes. The most
widely accepted form of this standardization is Evidence
Based Best Practices (EBBP). Furthermore, financial
health care providers such as hospitals and managed care
organizations are investigating methods to tie resource
usage to medical protocols in their efforts to monitor and
control health care costs. Such proposals are contentious
because they report on physicians’ medical practice
behaviors (such as the number of tests ordered, use of
specific therapies, etc.) and such reports could potentially
be used to influence their clinical behaviors. The intent of
this exploratory study was to examine physicians’
perceptions about linking a standard costing system to
EBBP guidelines. The authors interviewed nine practic-
ing physicians asking each physician to respond to the
question, ‘As a physician working in a hospital environ-
ment, what are your reactions to and concerns with
combining standard costing techniques with EBBP?’ The
interviews were in-depth and free form in nature. The
physicians’ responses were recorded and analyzed using
Grounded Theory Methodology. Using this methodol-
ogy the field data was categorized into two major themes.
The most important theme centered on ethics and the
second theme was concerned with the implementation
and use of a standard cost system in regard to EBBP. If
physicians’ worries about ethical dilemmas and imple-
mentation issues are not resolved, then it is likely that
doctors would be unwilling to participate in any efforts to
develop or use a standard cost-reporting system in med-
icine. While this study was exploratory in nature, it
should provide future guidance to accountants, health
care researchers and health care providers about physi-
cians’ issues with the use of standard costing methods in
medicine.
KEY WORDS: diagnostic related groups (DRGs),
evidence based best practices (EBBP), grounded theory
methodology, health care ethics, physician practices
Introduction
Healthcare costs in the United States have been
rising at an alarming rate over the last several dec-
ades, outpacing the Consumer Price Index. Cur-
rently, nearly 16% of the Gross Domestic Product
(GDP) is spent on health care (Kolata, 2006), and it
is projected to rise 7.3% annually for the next dec-
ade. By 2013 health care spending is projected to be
Gr.
This document summarizes a study examining whether hospitals shift costs from uninsured patients to private payers. The study replicates previous analyses using Texas hospital data from 2000-2007. Regression models relate private payer prices to Medicare, Medicaid, and uninsured prices. The results provide little evidence that hospitals shift costs to private payers from government or uninsured sources. The authors suggest further research on subsidies for uninsured care and better measures of market competition.
WealthTrust-Arizona - Five Fallacies for Improving Healthcare WealthTrust-Arizona
Educational workshop presented by WealthTrust-Arizona and world-renowned guest Robert K. Smoldt, Chief Administrative Officer Emeritus at Mayo Clinic and Associate Director of Healthcare Delivery & Policy Programs at Arizona State University. Mr. Smoldt has been involved in health care administration for more than 30 years and is currently pursuing U.S. health reform in close partnership with Mayo Clinic’s Emeritus President and CEO.
At this workshop Robert examines a number of general statements that are, in his view, fallacious.
Slides from a presentation Adrian gave on the subject of indication-based pricing at the 2018 ISPOR Europe conference in Barcelona, Spain on November 12th.
This document summarizes a report by the Massachusetts Division of Health Care Finance and Policy examining price variation for healthcare services in Massachusetts. Some key findings include:
- Prices paid for the same hospital and physician services varied significantly, with at least a three-fold difference for every service examined.
- Higher-priced hospitals tended to have higher patient volumes for the services analyzed.
- There was little correlation between hospital quality scores and prices paid, though some lower-priced hospitals had slightly higher quality scores.
- Modeling payments to reflect a narrower range could yield estimated savings of $267 million for hospital and physician services.
Copyright 2013 American Medical Association. All rights reserv.docxvanesaburnand
Copyright 2013 American Medical Association. All rights reserved.
Hospitals, Market Share, and Consolidation
David M. Cutler, PhD; Fiona Scott Morton, PhD
O ver the last few decades, what was once an independenthospital has increasingly become a health system cen-tered on inpatient institutions. Many health systems in the
market today generally have 1 or more academic medical center
“hubs,” surrounded by other community or short-term acute hos-
pital “spokes,” and ownership interest or close affiliations with phy-
sicians, clinics, rehabilitation facilities, and other health care prac-
titioners and organizations. Because hospitals are often the center
of the institution, medical care across the continuum is effectively
coming under the direct or indirect control of institutions that pro-
vide inpatient care.
Policy makers both revere and revile these health systems. On
the one hand, lack of coordination has long been seen as a key fail-
ure of US health care.1 Integrated health systems have the capacity
to address the quality deficiencies resulting from lack of coordina-
tion. On the other hand, health systems can become so large that
they are able to increase prices, harming consumers and taxpay-
ers. Thus, there are increasing calls for greater antitrust scrutiny of
hospital systems.2
Which of these views is right? Should big health systems be
treated the same as retailers or Internet companies that merge to
become dominant in their markets? Or should growth of health
care systems be encouraged in the name of efficiency and better
outcomes? In this Special Communication, we present data on
the growth of integrated systems, discuss the potential benefits
and harms of integration, and consider possible remedies.
Methods
Analysis of Hospital Markets
Our analysis of hospital markets is based on data from the Ameri-
can Hospital Association (AHA). We used data on nonfederal, short-
term general and specialty hospitals that have facilities and ser-
vices available to the public.
Information on hospital days and the number of hospitals over
time was derived from the AHA Chartbook.3 To understand how hos-
pital markets have become structured, we analyzed information for
the 306 hospital referral regions (HRRs) spanning the country, using
data from 2010. Hospitals were grouped into systems, with the hos-
pitals in each system treated as an entity. We considered systems only
within the same HRR. If a parent system had multiple hospitals in dif-
ferent HRRs, each HRR was considered separately so that we could
adequately assess the competitive environment in each HRR.
To characterize the competitive environment in the HRR, we used
2 metrics. First, we considered the share of admissions that are cap-
tured by a certain number of institutions (eg, the share of admissions
in the largest 3 hospitals or hospital systems). Second, we calculated
for each market using the Herfindahl-Hirschman Index4 (HHI) of con-
centration. This variable is the sum o.
Dr. Kapoor Tallahassee Democrat op-ed - Jan. 2013Rebecca Sage
This document discusses the trend of hospitals acquiring physician practices, which drives up healthcare costs. It notes that hospitals are reimbursed at higher rates than physicians' offices for the same services. This differential reimbursement has enabled hospitals to consolidate market control and employ more physicians, while the number in private practice has declined. However, hospitals are actually a more expensive and less efficient site of care. The document argues for equalizing reimbursement rates between hospitals and physicians' offices to help control costs and preserve patient access to healthcare.
The Economics of Innovative Payment Models Compared with Single Pricing of Ph...Office of Health Economics
The presentation summarises an OHE report, exploring the economic implications of permitting multiple prices where a medicine’s value differs by indication. It considers the impact on payer budgets, patient access, incentives for innovation, and the role of competition.
Author(s) and affiliation(s): Amanda Cole, OHE. Adrian Towse, OHE. Paula Lorgelly, OHE. Richard Sullivan, King's College London.
Event: Webinar presented to IQVIA based on our OHE Research Paper
Location: n/a
Date: 12/09/2018
Disaster Contact a disaster preparedness person at either a loca.docxlynettearnold46882
Disaster
Contact a disaster preparedness person at either a local hospital, or local city or county emergency services agency. NORTHEAST OHIO
1. Blackout 2003
2. Chardon Highschool shooting 2012
3. Great blizzard 1978
Interview your contact, asking the following questions:
1) "What do you consider to be the top three disasters for which you prepare?"
2) "What would you say are your top three lessons learned about managing a disaster?"
What Would the Best Future for Health Care Look Like?
Introduction
The one thing the debate over reforming health care taught us all is that there are as many opinions as there are interested groups, and all of them differ in meaningful ways. To look at the views on improving the systems of care delivery, it is important to note where they have points of agreement and where they differ. They are all driven by the values and principles of the constituencies and what they hope to achieve from changes in the delivery system. This module will explore points of agreement and differences between important groups that will influence the direction health care will go in the next decade.
Patients
It is an interesting point that all constituencies, in their public statements, emphasize that a strong health care system should focus on getting the best outcomes for patients. What would that be, from the perspective of patients? Typically, patients relate that they want top quality in their care and the latest technology, along with immediate and unrestricted access to care, at the lowest possible cost. This triad has become the stumbling block of change initiatives, since to date, no one has figured out how to deliver all three. However, when patients' views are explored and probed, some interesting facts emerge. When patients say they want top quality care, in general, they tend to define that as achieving a cure or return to health. They certainly do not want to leave the system feeling worse than when they came in. Patients have been heavily lobbied in the media by pharmaceutical and medical technology companies to convince them that the latest (and most expensive) technology will deliver the desired outcomes. However, very little real research on the true effectiveness of treatments and technology makes its way to most patients, and patients in general do not shop for their medical care as carefully as they would if they were purchasing new cars, for example. The language of research and medicine is difficult for patients to understand and is frequently not well-explained by providers.
So, the nuances of top quality care in terms of being able to deliver a cure or return to health are not well understood by the constituency with the most at risk. What patients do understand is whether they feel better or see improvement in their health and whether care was rendered without errors and in a compassionate way. The best health care system, from a patient's point of view, is one that can consistently deliver the good.
QuestionIn what settings is UCR utilized Do you think the .docxcatheryncouper
Question:
In what settings is UCR utilized? Do you think the patient should be informed by the type of reimbursement type ahead of time?
Notes from class
Overview of Reimbursement
This week, you will review the most common reimbursement methods used to compensate providers, including physicians, hospitals, outpatient, and ancillary facilities. The most common forms of payment are FFS and capitation. FFS is often criticized because it is assumed that with higher fees and higher volume, physicians make more money. FFS is often blamed for problems with controlling the overall cost of care and encouraging waste and fraud in the healthcare system.
FFS is considered a non-risk-based form of reimbursement because the payer (i.e. a Health maintenanace organization-HMO) is not sharing risk with the provider. FFS is most common among PPOs and traditional indemnity plans. Some examples of FFS include cost-based, charge-based, and prospective payment. Under cost-based reimbursement, the provider is reimbursed based on a predefined allowable costs. Payers pay billed charges to the provider under charge-based reimbursement. In a Prospective Payment System (PPS), payments are made based on categories: per procedure, per diagnosis, per diem, or by global pricing (Gapenski, 2003).
Capitation is a risk-based payment method most commonly used by HMOs, where a gatekeeper system is required. Capitation is most commonly used for primary care physicians in HMOs. Physicians are prepaid on a per-member-per-month (PMPM) basis. As long as the patient is a member of the physician's patient panel, the physician will receive payment, whether services were used or not. Capitation allows health plans to more effectively predict costs and is less costly to administer, because there are fewer claims to review (Gapenski, 2003).
Hospitals can only negotiate prices or contract with commercial or private insurers; Medicaid and Medicare set their own payments through the PPS, which is based on diagnosis-related groups (DRGs). A variety of methodologies may be used by the same payer. We will discuss these methodologies more under Hospital Reimbursement.
Per Diems and DRGs are used only for inpatient care. Thus, these methods cannot be applied to ancillary and ambulatory care patients. As care has shifted out of the hospitals to ambulatory facilities, the cost of care in these facilities has also increased. There are two classification groups related to reimbursements in these settings—ambulatory patient groups (APGs) and ambulatory payment classifications (APCs).
Question:
In what settings is UCR utilized? Do you think the patient should be informed by the type of
reimbursement type ahead of time?
Notes from class
Overview of Reimbursement
This week, you will review the most common reimbursement methods used to compensate providers, including
physicians, hospitals, outpatient, and ancillary facilities. The most common forms o
f payment are FFS and capitation. ...
The document discusses the challenges and limitations of the Physician Payments Sunshine Act, which requires drug and medical device companies to report payments and gifts provided to physicians. While intended to increase transparency, it faces issues in fully capturing all financial relationships and providing proper context. The data has had limited impact on physicians and patients, but is being utilized by other groups like researchers and lawyers. Overall, the Act faces obstacles in communicating complex financial data in a clear and meaningful way to different audiences.
4-1 Responses 1Healthcare services are always going to be .docxtroutmanboris
4-1 Responses
1
Healthcare services are always going to be needed, and prices will get higher with time; in fact, "Reimbursement just keeps growing over time, say the critics. A Washington Post analysis of records for 5,700 procedures reportedly showed that work RVUs are seven times likelier to increase than to fall" (Baltic, 2013.) The question that is needed to be asked is: What actions can be implemented in order to change and improve the current healthcare problematic? Here are some of the factors that can influence it:
1) Geographic position: The better positioned and available the hospital is, the more consumers can access to health and promote business. There are some other interesting choices that places like Oregon has implemented to help Medicare rates and allow more patient to be seen in community hospitals, which is known as a new Accountable Care Collaborative program "allowing to connect healthcare providers as well as social services and community-based assistance" (Johnson, 2013.)
2) Physician Alignment: Great physicians increase the visit numbers due to high success rates, which contributes to more financial stability and solvency for the hospital.
3) Cost structure: "Hospitals with a high-cost structure either due to high debt, high employee costs or the inability to amortize costs over larger revenues are more susceptible to bankruptcy" (Becker & Dunn, 2010.)
4) Quality of services: low-quality care increase bad reputation, which means no clients for the hospital. High mortality or nosocomial infections equal to poor care as well.
What do you think? Is it necessary to invest more in healthcare workers to increase patient satisfaction? Will that helps the quality of care? What do you think will happen with your cost structure?
Thanks
Reference
Baltic, S. (2013). PRICING MEDICARE SERVICES: Insiders reveal how it's done. Managed Healthcare Executive, 23(11), 28-40.
Becker, S., & Dunn, L. (2010, September 30). 7 Factors to Assess the Sustainability of a Hospital. Retrieved from https://www.beckershospitalreview.com/hospital-management-administration/7-factors-to-assess-the-sustainability-of-a-hospital-assessing-a-hospitals-viability-its-financial-situation-and-the-severity-of-the-threats-it-faces.html
Jonhson, S. R. (2013, September 09). Controlling costs. Modern Healthcare, 43(36), 7-12.
2
When there is more of a demand for health care services, organizations can see that there is more of a need to be cost efficient because there needs to be a balance between the cost that is made when using resources and as well as providing health care to our patients. Instead of breaking even, organizations should consider making revenue so that they can offer adequate pay for staff, allow for departmental growth with expansions and update supplies and technology to be competitive among other hospitals in the area.
As stated in our classroom textbook, Essentials of Healthcare Finance (8th Edition) written by William Cleverley a.
Hospital care accounts for approximately 30% of total national healthcare expenditures and is projected to remain at this level for the next decade. From 2000-2009, hospital revenues closely tracked rising cost increases, with both increasing by around 5% annually. Labor costs, which make up over half of hospital expenses, grew between 5-8% per year in this period. Additionally, hospitals face growing shortfalls from Medicare/Medicaid and uncompensated care. Analyses show hospital prices are directly related to their costs of providing services.
ORIGINAL RESEARCHDemographic Factors and Hospital Size Pre.docxgerardkortney
ORIGINAL RESEARCH
Demographic Factors and Hospital Size Predict Patient Satisfaction
Variance—Implications for Hospital Value-Based Purchasing
Daniel C. McFarland, DO1*, Katherine A. Ornstein, PhD2, Randall F. Holcombe, MD1
1Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, New
York; 2Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, New York.
BACKGROUND: Hospital Value-Based Purchasing (HVBP)
incentivizes quality performance-based healthcare by link-
ing payments directly to patient satisfaction scores
obtained from Hospital Consumer Assessment of Health-
care Providers and Systems (HCAHPS) surveys. Lower
HCAHPS scores appear to cluster in heterogeneous
population-dense areas and could bias Centers for Medi-
care & Medicaid Services (CMS) reimbursement.
OBJECTIVE: Assess nonrandom variation in patient satis-
faction as determined by HCAHPS.
DESIGN: Multivariate regression modeling was performed
for individual dimensions of HCAHPS and aggregate
scores. Standardized partial regression coefficients
assessed strengths of predictors. Weighted Individual (hos-
pital) Patient Satisfaction Adjusted Score (WIPSAS) utilized
4 highly predictive variables, and hospitals were reranked
accordingly.
SETTING: A total of 3907 HVBP-participating hospitals.
PATIENTS: There were 934,800 patient surveys by the
most conservative estimate.
MEASUREMENTS: A total of 3144 county demographics
(US Census) and HCAHPS surveys.
RESULTS: Hospital size and primary language (non–English
speaking) most strongly predicted unfavorable HCAHPS
scores, whereas education and white ethnicity most strongly
predicted favorable HCAHPS scores. The average adjusted
patient satisfaction scores calculated by WIPSAS approxi-
mated the national average of HCAHPS scores. However,
WIPSAS changed hospital rankings by variable amounts
depending on the strength of the predictive variables in the
hospitals’ locations. Structural and demographic characteris-
tics that predict lower scores were accounted for by WIPSAS
that also improved rankings of many safety-net hospitals and
academic medical centers in diverse areas.
CONCLUSIONS: Demographic and structural factors (eg,
hospital beds) predict patient satisfaction scores even after
CMS adjustments. CMS should consider WIPSAS or a simi-
lar adjustment to account for the severity of patient satisfac-
tion inequities that hospitals could strive to correct. Journal
of Hospital Medicine 2015;10:503–509. VC 2015 Society of
Hospital Medicine
The Affordable Care Act of 2010 mandates that gov-
ernment payments to hospitals and physicians must
depend, in part, on metrics that assess the quality and
efficiency of healthcare being provided to encourage
value-based healthcare.1 Value in healthcare is defined
by the delivery of high-quality care at low cost.2,3 To
this end, Hospital Value.
Similar to LDI Research Seminar- Hospital Choices, Hospital Prices and Financial Incentives to Physicians 11_4_11 (20)
This study analyzed insurance claims data from before and after the implementation of the Federal Mental Health Parity and Addiction Equity Act to examine the effects of parity on substance use disorder treatment. The results showed:
1) There was no change in the use of substance use disorder services or the total annual spending per enrollee on these services (which increased by only $10 per enrollee).
2) There was also no change in out-of-pocket spending for substance use disorder treatment users or several HEDIS quality measures related to identification and initiation of treatment.
3) This suggests that concerns about parity greatly increasing health care costs related to substance use disorder treatment were unfounded.
This study analyzed insurance claims data from before and after the implementation of the Federal Mental Health Parity and Addiction Equity Act to examine the effects of parity on substance use disorder treatment. The results showed:
1) There was no change in the use of substance use disorder services or the total annual spending per enrollee on these services (which increased by only $10 per enrollee).
2) There was also no change in out-of-pocket spending for substance use disorder treatment users or several HEDIS quality measures related to identification and initiation of treatment.
3) This suggests that concerns about parity greatly increasing health care costs related to substance use disorder treatment were unfounded.
This study compared retention rates, satisfaction, and safety between intimate partner violence (IPV) research participants paid via wireless gift cards versus cash. Participants receiving gift cards completed significantly more of the 12 weekly phone surveys (average 8.3 vs 6 calls). Over 90% of gift card recipients expressed satisfaction, and 60% preferred this method. While safety did not differ, wireless incentives may improve retention in repetitive IPV research that can involve remote data collection.
This study analyzed data from 658 insured pregnant women in a Midwestern county to compare risks and outcomes between those who did and did not utilize the emergency department (ED) during their peripartum period. The study found that 218 women (33%) visited the ED at least once during this time. ED users were more likely to experience psychosocial risks like postpartum depression and smoking, have poorer birth outcomes like prematurity, and have inadequate prenatal care. After adjusting for demographic factors, ED use was associated with a higher likelihood of postpartum depression, smoking during pregnancy, unstable housing, delayed prenatal care initiation, and missing a postpartum visit.
This study conducted a telephone survey of labor and delivery units at U.S. hospitals to determine the prevalence of hospital policies addressing non-medically indicated deliveries prior to 39 weeks gestation. They found that 66.5% of responding hospitals reported having such a policy. Hospitals in states with initiatives to reduce early deliveries were more likely to have a policy, with 67.8% of hospitals in initiative states reporting a policy compared to 62.1% in non-initiative states. The majority (68.8%) of policies were coded as having a "hard stop" against early deliveries. The study concludes that state initiatives can effectively encourage more hospitals to adopt restrictive policies on non-medically indicated early deliver
This study explored a broader range of adverse childhood experiences reported by low-income adults from Philadelphia compared to those measured in previous research. The researchers conducted focus groups with 119 participants who generated a list of childhood stressors across 10 domains. The most commonly reported experiences were issues within family relationships, community safety threats, personal victimization, and economic hardship. The study concludes that considering a wider range of adversities is important for understanding health impacts on low-income urban populations.
This document summarizes a mixed-methods study examining the relationship between mental health therapists' attitudes towards evidence-based practices (EBPs), perceptions of organizational factors, and degree status. The study found that doctoral-level therapists with positive attitudes reported more autonomy, while those with less positive attitudes reported requirements to use CBT and lack of time. Non-doctoral therapists reported lack of resources, space, funding, and regular client access as barriers. Managerial support was a facilitator for all therapists. The study provides insight into implementation challenges faced in community clinics from front-line perspectives.
This document proposes a model where doulas receive training in cognitive behavioral therapy (CBT) principles from staff at an integrated maternal wellness clinic. The objectives are to incorporate doulas into standard practice while providing training, and to utilize doulas to increase implementation of evidence-based CBT for common mental health issues in the perinatal period like anxiety and depression. Limitations include challenges of implementing a novel intervention and ensuring standardized training, protected staff time, and adherence to practice guidelines.
This study piloted a modified social skills intervention for children with ASD implemented by school personnel in public school settings. The intervention focused on facilitating peer engagement during lunch and recess. Results showed improvements in social network centrality and joint engagement for children who received the immediate treatment compared to those in the waitlist control. However, barriers like unclear staff roles, lack of support, and loss of recess time prevented long-term sustainability. Future work is needed to address school-level barriers to implementation and adapt interventions to fit individual school contexts.
This study examined the healthcare system supports for internists caring for young adult patients with chronic illnesses that began in pediatric care. Semi-structured interviews were conducted with 21 internists across 4 states. The interviews identified 5 major themes of healthcare system burdens experienced by internists, including difficulty identifying patients' medical teams, inadequate time for complex patients, significant administrative burden, lack of social/case management support, and financial constraints. The interviews also identified 3 potential strategies to improve supports, such as formalizing transfer processes, maximizing electronic records/communication, and leveraging patient-centered medical homes and bundled payments.
Most internists found more similarities than differences in caring for young adults with intellectual and developmental disabilities (I/DD) and elderly adults with dementia. Both populations require longer office visits and more staffing resources due to complex health histories. Obtaining records and coordinating care can be difficult for both. Reliance on advocates, community services for transportation and supervision, and vulnerability to insurance changes are also similarities. While specific diseases differ, models for geriatric care could potentially address supervision and caretaking needs for adults with I/DD. Strengthening safety net services would help low-income families and elderly patients with dementia or I/DD.
This study examines the association between patient perceptions of case manager performance and satisfaction with care, as well as the relationship between perceptions of case managers and primary care providers (PCPs) and subsequent healthcare utilization. The study analyzed survey and claims data from over 2,000 patients receiving primary care from a medical home model with embedded case managers. The results found that higher ratings of both case manager and PCP performance were independently associated with greater patient satisfaction. The study concludes by noting that perceptions of case management may impact health outcomes and behaviors, warranting further analysis of utilization patterns.
This document analyzes survey data from 2002-2010 on HIV testing rates and chronic disease screening in Southeastern Pennsylvania. It finds that HIV testing rates are lower than screening for other chronic diseases. Populations receiving care at community health clinics, emergency rooms, or with no primary care are more likely to get HIV testing than those at private clinics. While community health clinics perform similar to private clinics on chronic disease screening, those using emergency rooms or with no primary care are less likely to receive routine chronic disease screening. Primary care physicians adhere to guidelines for screening of conditions like blood pressure and cancer but may neglect appropriately screening for HIV.
This study analyzed survey data from 50,698 individuals in Southeastern Pennsylvania between 2002-2010 to compare HIV testing rates to other routine health screenings. It found that HIV testing rates were lower than for other conditions. Those receiving care at community health clinics, emergency rooms, or with no primary care had higher odds of receiving an HIV test compared to private clinics. While community health clinics performed similarly to private clinics on other screenings, emergency rooms and no primary care had lower rates. The study suggests primary care physicians may neglect appropriate HIV screening of patients despite adhering to other screening guidelines.
1. The document discusses high value cost conscious care and whether it constitutes rationing or rational care.
2. It notes that health care costs in the US continue to rise significantly each year, with diagnostic imaging being a major driver of increasing costs.
3. Data from 6 large health systems showed large variations in diagnostic imaging rates between different regions without clear clinical benefits, indicating opportunities for more rational use of imaging to improve quality and reduce costs.
This document summarizes key findings from RAND research on health care spending in the United States. It finds that between 1999-2009, health care costs grew substantially for a median-income American family, consuming money that could have otherwise been used to pay down debt, save for retirement, or pay for education. While Americans received more medical services, the quality of care was still suboptimal, with recommended care received only about 55% of the time. The document also examines different approaches to reducing health care costs, finding that high-deductible health plans with deductibles over $1,000 were effective in reducing spending.
The document outlines Marc Atkins' presentation goals which include reviewing concerns with the current U.S. children's mental health care system, justifying a focus on schooling using ecological principles and a public health framework, presenting an experimental intervention model and preliminary results, and discussing future directions. It then lists the collaborators involved in the research from various universities.
The document summarizes a study that analyzes the effects of the 2010 Affordable Care Act's dependent coverage mandate on young adults' health insurance coverage and labor market behavior using data from the 2008 panel of the Survey of Income and Program Participation. The study finds that the policy led to a 3.3 percentage point reduction in uninsurance among young adults ages 19-25, a 6.2 percentage point increase in dependent coverage through a parent's employer-sponsored insurance, and evidence of increased labor market flexibility for young adults.
This document provides a template for creating scientific posters. It includes suggestions for formatting, design principles, and sections like the title, abstract, methods, results, and conclusions. The template is meant to simplify poster creation and emphasize key points for viewers through techniques like italics, boldface, and effective use of space. Proper formatting of images, tables, and graphs is also discussed. The goal is to design posters that are easy to understand and focused on the needs of the audience.
1) Current state of quality and safety in healthcare is poor, with routine safety processes failing regularly and preventable adverse events occurring commonly.
2) High reliability organizations like commercial aviation have achieved much higher levels of safety through effective process improvement, a strong safety culture, and principles of collective mindfulness.
3) The Joint Commission aims to transform healthcare into a high reliability industry through initiatives like robust quality measurement, establishing accountability criteria for measures, and promoting high reliability principles.
More from Leonard Davis Institute of Health Economics (20)
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
LDI Research Seminar- Hospital Choices, Hospital Prices and Financial Incentives to Physicians 11_4_11
1. Hospital Choices, Hospital Prices and Financial
Incentives to Physicians
Kate Ho and Ariel Pakes
November 2011
Ho and Pakes () Hospital Choice 11/11 1 / 36
2. Motivation
March 2010 health reforms include physician …nancial incentives to
control costs in the Medicare and Medicaid programs
Accountable Care Organizations share cost savings
Physicians receive bundled payments for episodes including
hospitalizations
Goal: cost control without compromising quality
Similar cost control incentives currently used by health maintenance
organizations (HMOs) for private enrollees in California
Previous papers document lower costs in HMOs compared to other
insurers but not the mechanisms used.
This paper: do patients whose physicians have a …nancial incentive to
control costs receive care at lower-priced hospitals?
Ho and Pakes () Hospital Choice 11/11 2 / 36
3. Motivation cntd.
A substantial previous literature uses hospital discharge records to
estimate models of hospital choice
Important for regulatory analysis (e.g. hospital mergers and
investment)
How much do decision-makers value each hospital?
How much would the valuation change after merger/investment?
But previous papers largely ignore impact of price paid by the insurer
to the hospital.
We address this issue. Are hospital choices ever in‡uenced by price paid by
insurer to hospital?
Ho and Pakes () Hospital Choice 11/11 3 / 36
4. Outline
Overview of the Market and the Model
Why should choices respond to hospital prices?
How will we estimate price sensitivity?
Previous Literature
The Data
The Model
Multinomial Logit Analysis
Inequalities Methodology
Results and Conclusion
Ho and Pakes () Hospital Choice 11/11 4 / 36
5. The California Medical Care Market 2003
Focus on HMOs (53% of employed population)
7 largest HMOs had 87% of HMO market: we consider all but Kaiser
Physician contracts: California Delegated Model dominates
HMOs have non-exclusive contracts with large physician groups
Two payment mechanisms for physician groups
Capitation payments (…xed pmt per patient to cover services
provided): physician groups have incentives to control hospital costs
Global capitation: payment covers both primary care and hospital stays
Non-global include "shared risk arrangements" (group shares in
inpatient cost savings made relative to pre-agreed target)
These incentives are passed on to individual physicians
Alternative: fee-for-service contracts do not generate these incentives.
Ho and Pakes () Hospital Choice 11/11 5 / 36
6. Implications for Analysis
We utilize hospital discharge data for California in 2003, focus on
women in labor
Dataset does not identify patients’physician groups or details of
compensation schemes
We observe each patient’ insurer and percent of each insurer’
s s
payments for primary services that are capitated
Considerable dispersion across insurers
Blue Cross: 38% capitated payments
Paci…care: 97% capitated payments
Questions: Are hospital choices in‡uenced by price? Does price matter
more when the patient is enrolled in a high-capitation insurer?
If so, physicians likely to be responding to incentives generated by
capitation contracts.
Ho and Pakes () Hospital Choice 11/11 6 / 36
7. Possible Mechanisms for Causal E¤ect
Obstetrician (OB) often a¢ liated with 1-3 hospitals
Patient chooses OB based partly on hospital a¢ liation
Interview evidence indicates physician group practice managers pass
on price information to OBs.
Two possible mechanisms
Within-physician di¤erential treatment of patients
Consistent with previous literature
e.g. Melichar (2009), capitated patients have shorter visits than others
within-physician
Physicians with majority capitated patients use the cheaper hospital;
others do not
More likely if some obstetricians a¢ liated with a single hospital.
Ho and Pakes () Hospital Choice 11/11 7 / 36
8. Overview of the Model
Estimate utility of physician/patient agent making hospital choice:
Wi ,π,h = θ p,π (pricei ,π,h ) + gπ (qh (s ), si ) + θ d d (li , lh ) + εi ,π,h
pricei ,π,h = price paid by insurer to hospital for patient i’ services
s
d (li , lh ) = distance between hospital and patient’ home
s
si = measure of patient severity
qh (s ) = vector of perceived qualities for di¤erent sickness levels
gπ (.) = ‡exible function interacting qh (s ) and si
Permits hospitals to have higher quality for some sickness levels
And preferences for quality to di¤er across severities
Ideally would interact every severity group with hospital F.E.s.
Questions: Is the price coe¢ cient negative? Is it more negative when
insurer gives physicians incentive to control costs?
Ho and Pakes () Hospital Choice 11/11 8 / 36
9. An Additional Issue: PPOs
PPO as well as HMO enrollees sometimes included in the data
For BS and BC only (lowest-capitation insurers in data)
Cannot identify HMO enrollees separately from PPO
Same mechanism for admission to hospital except that patient can go
out-of-network if pays extra
OOP prices may also be di¤erent:
HMOs: small copay (approx $200) for inpatient visit
PPOs: may have coinsurance rate (higher out-of-network)
We drop hospitals to which very few patients admitted (likely
out-of-network)
Our inequalities method allows patients to have di¤erent
preferences/discretion in di¤erent insurers
Prices: KFF Survey 2003 suggests only 15% pay coinsurance rate, but
still may a¤ect interpretation of results.
Ho and Pakes () Hospital Choice 11/11 9 / 36
10. Previous Literature
HMO cost controls: consider whether managed care plans (which have
restricted networks & give physicians cost-control incentives) reduce costs
Glied (2000) review: HMOs have lower admission rates and costs
Cutler, McClellan, Newhouse (2000): HMOs have 30-40% lower
expenditures, largely due to lower price per treatment
Gaynor, Rebitzer and Taylor (2004): spending on utilization increases
with the size of physician groups receiving group-based …nancial
incentives in a single HMO
Hospital choice models: utility is a function of distance, hospital quality,
hospital-patient interactions
Often multinomial logit models; don’ include price paid by insurer
t
Examples: Luft et al (1990), Burns & Wholey (1992), Town &
Vistnes (2001), Capps et al (2003), Tay (2003), Ho (2006)
Gaynor & Vogt (2003) construct a price index at hospital level.
Ho and Pakes () Hospital Choice 11/11 10 / 36
11. Preview of the Results
Multinomial logit analysis (follows previous literature):
Limited controls for hospital quality (price endogeneity)
θ p,π positive when insurers and patients pooled
Negative coe¢ cient for less-sick patients
More negative for high-capitation insurers
Inequalities analysis:
Write down inequality constraints describing patient choices
Sum over patients to di¤erence out quality-severity terms gπ (.)
Address price endogeneity issues
θ p,π negative for almost all insurers when patients pooled
More negative for high-capitation insurers
Larger magnitudes than for logits
No need to restrict to least-sick patients
Ho and Pakes () Hospital Choice 11/11 11 / 36
12. The Dataset
Hospital discharge data from California 2003 (OSHPD data)
Census of hospital discharges, private HMO enrollees (and PPO for
BS / BC): women in labor
Patient characteristics: insurer name, hospital name, diagnoses,
procedures, age, gender, zip code, list price
Hospital characteristics: average discount, zip code, teaching status,
number of beds, services, annual pro…ts.
Ho and Pakes () Hospital Choice 11/11 12 / 36
13. The Price Variable
Price paid to hospital is unobserved
Instead: list price (equivalent to hotel "rack rate") and average
discount at hospital level
Calculate expected list price = average list price for ex ante similar
patients at the relevant hospital
De…ne price = expected list price*(1-average discount)
Likely to encounter issues with measurement error
Potential speci…cation error due to average discount variable will be
addressed as a …nal step.
Ho and Pakes () Hospital Choice 11/11 13 / 36
14. Descriptive Statistics: Discharge Data
Mean Std Devn.
Number of patients 88,157
Number of hospitals 195
Teaching hospital 0.27
List price ($) $13,312 $13,213
List price*(1-discount) $4,317 $4,596
Length of Stay 2.54 2.39
Died 0.01% 0.004%
Acute Transfer 0.3% 0.02%
Special Nursing Transfer 1.5% 0.04%
Ho and Pakes () Hospital Choice 11/11 14 / 36
15. Prices and Outcomes By Patient Type
N Price*(1-disc) Acute Transfer Special Nursing
Age
<40 84130 4269 (4488) 0.3% (0.0%) 1.49% (0.0%)
>40 4027 5310 (6373) 0.5% (0.1%) 1.54% (0.2%)
Charlson
0 86326 4276 (4501) 0.3% (0.0%) 1.5% (0.0%)
1 1753 6079 (7060) 0.6% (0.2%) 2.3% (0.4%)
>1 78 10022 (15186) 5.1% (2.5%) 12.8% (3.8%)
Notes: Labor diagnosis only. Charlson score (Charlson et al, 1986, Journal
of Chronic Diseases): clinical index that assigns weights to comorbidities
other than principal diagnosis where higher weight indicates higher
severity. Values 0-6 observed in data.
Ho and Pakes () Hospital Choice 11/11 15 / 36
16. Multinomial Logit Analysis
Equation to be estimated:
Wi ,π,h = θ p,π (δh lp (ci , h)) + gπ (zh , x (si )) + θ d d (li , lh ) + εi ,π,h
δh = 1 - discount; lp (ci , h) = average list price of patient type ci
Assume εi ,π,h distributed i.i.d. Type 1 extreme value
De…ne gπ (zh , x (si )) = qh + βzh x (si ) where
qh : hospital …xed e¤ects, zh : hospital characteristics
x (si ): P(adverse outcomes j age, principal diagnosis, Charlson score)
Caveat(s): No controls for measurement error. Price endogeneity problems
if some unobservable not captured by gπ (.) a¤ects choices and is
correlated with price.
Ho and Pakes () Hospital Choice 11/11 16 / 36
17. Results: Logit Analysis 1
All labor Least sick Sickest patients
Price 0.010** (0.002) -0.017* (0.009) 0.012** (0.002)
Distance -0.215** (0.001) -0.215** (0.002) -0.217** (0.002)
Distance squared 0.001** (0.000) 0.001** (0.000) 0.001** (0.000)
zh x (si ) interactions Y Y Y
(15 coe¤ts)
Hospital F.E.s Y Y Y
(194 coe¤ts)
N 88,157 43,742 44,059
Notes: Least sick patients are aged 20-39 with zero Charlson scores and all
diagnoses "routine"
Ho and Pakes () Hospital Choice 11/11 17 / 36
18. Results: Logit Analysis 2
Least sick patients
% capitated Discharges Estimates
Price x
Paci…care 0.97 7,633 -0.077** (0.01)
Aetna 0.91 3,173 -0.011 (0.016)
Health Net 0.80 8,182 -0.038** (0.01)
Cigna 0.75 4,001 -0.021 (0.014)
Blue Shield 0.57 7,992 0.018 (0.011)
Blue Cross 0.38 12,761 0.008 (0.011)
Distance -0.215** (0.002)
Distance squared 0.001** (0.000)
zh x (si ) controls Y
Hospital F.E.s Y
N 43,742
Notes: Least sick patients are aged 20-39 with zero Charlson scores and all
diagnoses "routine"
Ho and Pakes () Hospital Choice 11/11 18 / 36
19. Magnitude of Logit Results
Distance:
Consider impact of a 1 mile increase in distance for hospital h, holding
all else …xed, on probability Pih that patient i attends hospital h
Mean (std) distance for less-sick patients: 6.45 (10.11) miles
Average e¤ect: a 13.7% reduction in Pih
Price:
Similar exercise: a $1000 price increase for hospital h
Mean (std) price for less sick patients: $3380 ($1870)
Average e¤ect for Paci…care enrollees: a 5.2% reduction in Pih
Paci…care price-distance trade-o¤:
1 ∂di pi
η d ,p =
n ∑ ∂pi . di = 0.33
i
Ho and Pakes () Hospital Choice 11/11 19 / 36
20. Inequalities Analysis
Decision-maker utility from (i, π, h) is
Wi ,π,h = θ p,π (δh lp (ci , h)) + gπ (qh (s ), si ) + θ d d (li , lh )
De…ne ci , si in much more detail than logit equivalents
gπ (qh (s ), si ) interacts severity dummies with hospital F.E.s
Assumption: gπ (.) absorbs all unobserved quality variation known to
decision-maker that a¤ect hospital choice
Remaining unobservable is measurement error s.t. E (εi ,π,h j Ii ,π ) = 0:
Wi ,π,h = θ p,π (δo lp o (cio , h)) + gπ (qh (s ), sio )
h d (li , lh ) + εi ,π,h
Ho and Pakes () Hospital Choice 11/11 20 / 36
21. Inequalities Analysis, Intuition
Identifying assumption: for every patient ih , utility from chosen hospital h
>= that from any alternative h0
Wih ,π,h Wih ,π,h 0
Notation:
W (ih , h, h0 ) = Wih ,π,h Wih ,π,h 0 0.
Intuition: …nd all pairs of same-π, same-s, di¤erent-c patients ih , ih 0 s.t.:
ih visited h and had alternative h0
ih 0 visited h0 and had alternative h
Sum their inequalities. Equal and opposite gπ (.) terms drop out. Take
expectations on data-generating process to address εi ,π,h .
Ho and Pakes () Hospital Choice 11/11 21 / 36
22. Inequalities Analysis, Details
Patient ih and ih 0 utility di¤erences (noting that sio = sio 0 = s o ):
h h
W (ih , h, h 0 ) = θ p,π .p o (ih , h, h 0 ) + gπ (qh , s o ) g π (qh 0 , s o ) d (ih , h, h 0 ) + ε(ih , h, h 0 ) 0
W (ih 0 , h 0 , h ) = θ p,π .p o (ih 0 , h 0 , h ) + gπ (qh 0 , s o ) g π (qh , s o ) d ( ih 0 , h 0 , h ) + ε ( ih 0 , h 0 , h ) 0
Sum expressions; take expectations cndnal on decision-maker’ information
s
set:
E ( θ p,π (p o (ih , h, h 0 ) + p o (ih 0 , h 0 , h )) (d (ih , h, h 0 ) + d ih 0 , h 0 , h ) j Ii ,π ) 0
Sum over alternatives h0 > h and patients:
θ p,π ∑ ∑ (p o (ih , h, h0 ) + p o (ih 0 , h0 , h ))
0
∑ ∑ (d (ih , h, h0 ) + d
0
ih 0 , h 0 , h ) .
h >h ih ih 0 h >h ih ih 0
Ho and Pakes () Hospital Choice 11/11 22 / 36
23. Inequalities: Instruments
Add moments by interacting inequalities with instruments z:
Assumption: E (ε j z ) = 0
Positive and negative parts of distance di¤erences
Perfectly observed by econometrician, known to physician/patient
when choices made.
Conduct analysis for each insurer separately
73 - 283 moments per insurer
Divide each moment by its estimated standard error
Identify set of θ p,π satisfying implied system of inequalities
If none: …nd θ p,π to minimize amount by which inequalities violated.
Ho and Pakes () Hospital Choice 11/11 23 / 36
24. Inequalities: Variable De…nitions
Assumption: gπ (qh (s ), sio ) absorbs all unobservables known to
decision-maker that a¤ect hospital choice
interact narrow sio groups with hospital F.E.s
obstetrical experts ranked diagnoses 1-3
sio : age x principal diagnosis x Charlson score x diagnosis input x rank
of most serious comorbidity
106 populated groups x 157 hospitals.
Ho and Pakes () Hospital Choice 11/11 24 / 36
25. Inequalities: Variable De…nitions 2
Assumption: cio de…ned such that cio j sio a¤ects price but not choices
directly
must be more detailed than sio , otherwise price terms drop out
taking expectations addresses measurement error from small samples
cio : sio x number of highest-ranked comorbidities (272 populated grps)
obstetrical expert advice: number of diagnoses, conditional on their
rank, a¤ects price but not hospital referral.
Price variation: Moving from severity to price groupings explains an
additional 12% of variance in price (from 50% to 62% of total variance).
Ho and Pakes () Hospital Choice 11/11 25 / 36
26. Summary of Inequalities Analysis
Limitations of this methodology
Assume unobservables causing endogeneity bias absorbed in gπ (.)
Bene…ts:
Di¤erencing out the gπ (.) terms makes detailed hospital quality -
patient severity controls possible
Summing / averaging over patients addresses measurement error
problems in price variable
Requires no assumption on distribution of unobservables
Allows for selection of patients into insurers based partly on hospital
preferences (gπ (.) terms di¤er across insurers)
Also accounts for di¤erent preferences of PPO enrollees.
Ho and Pakes () Hospital Choice 11/11 26 / 36
27. Estimating Variation in Discounts Across Insurers
Final step: address speci…cation error in discount variable
Observe dh : average across insurers for each hospital
Use data on percent of h’ revenues from each π as input to
s
estimation of dπ,h
Specify logistic functional form so that dπ,h 2 [0, 1]
Estimate by NLLS. Explanatory variables include
hospital charas (e.g. teaching, FP, share of beds in market)
market …xed e¤ects, insurer …xed e¤ects.
Results intuitive: discounts high when hospital "bargaining power" low
Discount not signi…cantly related to insurer percent capitation.
Use estimates to generate prediction of dπ,h ) price measure.
Ho and Pakes () Hospital Choice 11/11 27 / 36
28. Results: Inequalities Analysis
Using observed discounts dh :
% capitated ˆ
θ p,π [CILB , CIUB ]
Paci…care 0.97 -1.34** [-1.55, -1.09]
Aetna 0.91 -4.34** [-5.84, -4.20]
Health Net 0.80 -0.37** [-0.67, -0.23]
Cigna 0.75 -0.80** [-0.92, -0.77]
Blue Shield 0.57 0.04 [-0.36, 0.47]
Blue Cross 0.38 -0.47** [-0.48, -0.09]
Ho and Pakes () Hospital Choice 11/11 28 / 36
31. Results: t-statistics for Inequalities Analysis
We calculate t-statistic for each moment = value of moment at
estimated θ p,π (inequality divided by estimated standard error)
Model implies all t-statistics 0
Estimates quite close to this:
Paci…care Aetna Health Net Cigna Blue Shield Blue Cross
Summary of t-statistics
# positive 152 71 166 88 162 247
# negative 9 2 11 2 7 36
Ave positive 11.1 19.4 14.5 17.0 17.0 20.1
# t < -2 0 0 2 0 0 7
We exclude moments with t < 2 for Health Net and Blue Shield.
Ho and Pakes () Hospital Choice 11/11 31 / 36
32. Magnitude of Results
η d ,p = percent distance reduction needed to compensate for a 1%
price increase:
Logits Inequalities
(less-sick patients) (all patients)
Insurer % cap η d ,p η d ,p
Paci…care 0.97 0.33 9.90
Cigna 0.75 0.10 5.65
Ineqs: results implied by speci…cation using δh as discount measure.
Ho and Pakes () Hospital Choice 11/11 32 / 36
33. Alternative Explanations
Blue Cross and Blue Shield data includes PPO enrollees
We drop hospitals likely to be out-of-network
gπ (.) terms control for di¤erent patient preferences across plans
Small di¤erence in OOP pricing strategies: if patients more price-elastic
than physicians this biases results against us
Blue Cross and Blue Shield unobservably di¤erent in other ways
Historically di¤erent: tax-exempt as social welfare plans, focused on
Medicare administration / government employee coverage
But no longer tax-exempt; not major Medicare providers; BC is FP
BS: NFP status may help explain wide con…dence intervals.
Ho and Pakes () Hospital Choice 11/11 33 / 36
34. Robustness Tests
Referring physicians may respond to capitation payments by reducing
quantity (rather than choosing cheaper hospitals)
Regressed "severity-adjusted" list price on insurer capitation and
market F.E.s, then add hospital F.E.s
With market FEs: negative capitation coe¢ cient
With hospital FEs: coe¢ cient positive and insigni…cant.
Discounts may di¤er across diagnoses within (π, h).
birth
Estimated discount regression allowing dπ,h = γdπ,h . Estimated
γ = 1.06 (S.E. 0.23)
Little e¤ect on inequality results.
Ho and Pakes () Hospital Choice 11/11 34 / 36
35. Conclusions
Objectives:
Estimate preferences of the agent that determines hospital choice
Identify whether physician incentives a¤ect price sensitivity
Inequalities method allows us to:
address endogeneity and measurement error concerns
remove assumptions on error term distribution
allow for patient selection into insurers based on hospital prefs.
More work to do on inequalities analysis
Price matters more when insurer capitates more physicians
Results have potentially important implications
for the impact of the U.S. health reforms on costs
and for understanding hospital merger and investment incentives.
Ho and Pakes () Hospital Choice 11/11 35 / 36
36. Comparison of High- and Low-Capitation Insurers
Percent 2002 Enrollment (000’s) Tax Prem IP day Presc
Capitn Comm Mcare M-Cal stat pmpm /1000 pmpm
Paci…care 0.97 1,543 386 0 FP 149.92 156.5 20.48
Aetna 0.91 486 37 0 FP 152.42 139.8 23.15
Health Net 0.80 1,665 101 350 FP 184.92 137.8 21.08
Cigna 0.75 635 0 0 FP - 137.1 15.63
Blue Shield 0.57 2,231 67 0 NFP 146.33 176.4 20.51
Blue Cross 0.38 3,486 251 1,099 FP 186.86 142.4 20.92
Ho and Pakes () Hospital Choice 11/11 36 / 36